Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Iterum Therapeutics plc ITRM | RA Capital Management, L.P. | 633,492 9.700% | 633,492 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | RA Capital Management, L.P. | 1,000,000 7.000% | 1,000,000 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Geron Corporation GERN | RA Capital Management, L.P. | 31,114,941 9.990% | 31,114,941 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Helix Acquisition Corp. HLXA | RA Capital Management, L.P. | 700,000 5.900% | 700,000 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | ImmunoGen, Inc. IMGN | RA Capital Management, L.P. | 18,417,458 9.800% | 18,417,458 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | FIVE PRIME THERAPEUTICS INC FPRX | RA Capital Management, L.P. | 4,285,161 9.800% | 4,285,161 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | RA Capital Management, L.P. | 2,129,003 5.600% | 2,129,003 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Kinnate Biopharma Inc. KNTE | RA Capital Management, L.P. | 3,593,052 8.300% | 3,593,052 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Inozyme Pharma, Inc. INZY | RA Capital Management, L.P. | 2,003,653 8.600% | 2,003,653 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | RA Capital Management, L.P. | 1,515,151 9.900% | 1,515,151 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Akouos, Inc. AKUS | RA Capital Management, L.P. | 2,281,249 6.600% | 2,281,249 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | RA Capital Management, L.P. | 815,849 6.300% | 815,849 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | MacroGenics, Inc. MGNX | RA Capital Management, L.P. | 4,375,217 7.800% | 4,375,217 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | RA Capital Management, L.P. | 2,150,404 5.400% | 2,150,404 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | PANDION THERAPEUTICS INC PAND | RA Capital Management, L.P. | 1,770,023 6.000% | 1,770,023 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RA Capital Management, L.P. | 2,327,714 7.800% | 2,327,714 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL | RA Capital Management, L.P. | 5,290,481 5.300% | 5,290,481 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Ardelyx, Inc. ARDX | RA Capital Management, L.P. | 24,652,344 6.800% | 2,543,992 (+11.51%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | ChemoCentryx, Inc. CCXI | RA Capital Management, L.P. | 4,776,548 6.900% | 1,577,159 (+49.30%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | ARYA SCIENCES ACQUISITION CORP ARYA | RA Capital Management, L.P. | 1,000,000 6.700% | 1,000,000 (New Position) | Filing History |